Skip to main content
Chana Weinstock, MD, Oncology, Baltimore, MD, Veterans Affairs Maryland Health Care System-Baltimore Division

ChanaWeinstockMD

Oncology • Baltimore, MD

Clinical Instructor, Internal Medicine, University of Maryland School of Medicine

Join to view full profile

Dr. Weinstock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Weinstock's full profile

Already have an account?

  • Office

    22 S Greene St
    Hematology Oncology, S9d10
    Baltimore, MD 21201
    Phone+1 410-328-7157
    Fax+1 410-328-6896
  • Is this information wrong?

Education & Training

  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Icahn School of Medicine at Mount Sinai (Beth Israel)
    Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Internal Medicine, 2005 - 2008
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 2005

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2011 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014

Publications & Presentations

PubMed

Lectures

  • An FDA analysis of the association between adverse events and outcome in patients with urothelial cancer receiving a programmed death protein 1 or programmed death lig... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Impact of antibiotic use on clinical outcomes in patients with urothelial cancer receiving a programmed death protein 1 or programmed death ligand 1 (anti-PD-1/L1) ant... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Checkpoint Inhibitors in Heavily Pretreated Bladder Ca: Long-Term Data
    Checkpoint Inhibitors in Heavily Pretreated Bladder Ca: Long-Term DataAugust 23rd, 2019
  • Urothelial Carcinoma Drug Shortages: Insights From ASCO GU
    Urothelial Carcinoma Drug Shortages: Insights From ASCO GUFebruary 6th, 2024

Hospital Affiliations

Dr. Chana Weinstock, Dr. Chana Weinstock, MD, Dr. C Weinstock